Mercado brasileiro de medicamentos genéricos: análise do desemprenho de uma subsidiária de laboratório estrangeiro

The pharmaceutical industry is a segment that is dominated by transnational companies. This characteristic is visible in Brazil, where there are only three domestic laboratories in the top ten pharmaceutical companies list. From the 1970s onwards, the world pharmaceutical market went through deep changes caused mainly to the increase of regulatory control and patent expiration that led to the advent of generic medicaments. In 1999, it was published the law that allowed the introduction of generic medicaments in Brazil, creating a new market that is currently dominated by domestic laboratories. This dissertation proposes to identify the reasons for a subsidiary of foreign laboratory does not achieve the leadership of this market. The literature is based on international political economy and international business concepts that means, relations between subsidiary and head office, domestic and foreign companies and government. Four propositions are presented and tested through multiple sources of evidences. The empirical research was mainly grounded in interviews with key persons and participant observation that allowed access to information, which would be not available for scientific investigation. The results indicate that the relationships considered in this study affect the subsidiary performance in generic medicament market in regard to its ability to make decisions, price competitiveness and wide portfolio creation. The respondents considered those three aspects as success critical factors. The results can be used for future research, aiming to wide the focus of the study about domestic laboratory dominance in generic medicament markets. Another suggestion is to follow this market evolution regarding to the internationalization process of domestic laboratories.

Estudo da influência das competências dos níveis operacionais sobre os processos de estratégia: o caso da empresa farmacêutica MERCK S.A

Based on the approaches and studies on the subject of organizational strategies aimed at intra-firm aspects, resources and competencies developed by organizations have been identified as the key elements toward assessing and explaining a company¿s performance. Considering such perspective, it has been observed that the development and effective implementation of organizational strategies depend on the skills and knowledge supplied by workers who are motivated or led to contribute with their effort so as to meet the organization¿s goals. Considering this, the purpose of this dissertation is to identify how the competencies of the operational levels of an organization are mobilized to contribute to the shaping and implementation of organizational strategies. This assessment was accomplished by observing the existing relationships between organizational and human resources management processes and processes of short term and long term strategies in a company of the pharmaceutical industry. The analysis of the evidence collected during the observation of this company has shown a strong link between personnel processes and the accomplishment of short term strategic goals, and a weaker link with the establishment of long term strategies. As a rule, the corporation¿s operational levels have little influence on the strategic planning and its implementation, even though the company uses a model of competencies designed to create more effective and measurable relationships between individual competencies and the company¿s performance.

Entry strategies into biosimilars: assessment of entry modes into the field of biosimilars from the perspective of pharmaceuticals, generics and biologics companies

Indústria farmacêutica de hoje está em transição. Como grandes blockbuster drogas estão perdendo ou estão prestes a perder a proteção de patente, e as grandes empresas farmacêuticas não estão substituindo os produtos com novas drogas químicas inovadoras, a indústria busca novas áreas de crescimento. Uma dessas áreas é o mercado de biossimilares, que está sendo inseridos por produtos farmacêuticos, genéricos e empresas de produtos biológicos. Mesmo que o grande potencial de mercado será acordado por volta de 2020, quando importantes blockbusters biológicos perder a proteção de patente, as empresas precisam decidir logo se querem participar ou não devido a elevadas barreiras à entrada técnicos, bem como de desenvolvimento de longo prazos. Como todas as empresas vêm de diferentes origens, compreendem capacidades diferentes e têm diferentes incentivos de entrada, a questão que surge é se esses fatos estão relacionados com as suas estratégias de entrada correspondentes. A tese utiliza estudos de caso de cada segmento da indústria farmacêutica - produtos farmacêuticos, biológicos e genéricos - e examina através de entrevistas semi-estruturadas, por isso que os participantes do estudo de caso entrevistados explicitamente escolhido sua estratégia de entrada. Os dados de entrevistas será então ligada a quadros estratégicos da revisão da literatura e irá ser utilizado para uma comparação global e análise. O estudo revelou que o fundo do participante do mercado que influenciam a sua estratégia de entrada. Os principais pontos de influência derivam tanto as barreiras à entrada, bem como os incentivos de entrada. A tese não é possível determinar o sucesso futuro do modo de entrada analisados no novo mercado.

Patentes como instrumento de aumento de dependência tecnológica e econômica: estudo da indústria farmacêutica

A dependência brasileira, na indústria farmacêutica/farmoquÍmica, em relação aos interesses e capitais estrangeiros é extremamente elevada e incompatível com as dimensões de mercado que o país representa e com os interesses nacionais. Por outro lado, é praticamente, nulo o trabalho de pesquisa básica no setor, aqui realizado, seja por empresas nacionais ou, principalmente, estrangeiras. Comumente,alega-se que a falta de pesquisa no setor' é decorrência do não reconhecimento de patentes de produtos e respectivos processos de produção. Este trabalho procura demonstrar que a causa básica da dependência tecnológica e, consequentemente, econômica no setor não tem relação significativa com a legislação que não reconhece tais patentes. Ao contrário, o sistema de patentes pode conduzir a um maior grau de dependência para os países em desenvolvimento. Além disto, constata-se que, apesar de o Brasil ser o principal país sob o processo de desenvolvimento dependente, no setor farmacêutico/farmacoquímico nos encontramos ainda num estágio de total dependência, sem desenvolvimento significativo, porque os capitais estrangeiros são para cá dirigidos com o fim de simplesmente explorarem o mercado local, sem o intuito de transferir "know-how" e equipar tecnologicamente a base industrial a qui existente. Tais aspectos, abordados à luz dos conceitos da Teoria Geral do Imperialismo e da Teoria do Desenvolvimento Dependente, são analisados conjuntamente com a evolução histórica do setor no Brasil e com os fatores determinantes dessa atual situação de dependência econômica e tecnológica.

Relacionamento com médicos como estratégia de marketing da indústria farmacêutica

O marketing de relacionamento (MR) é uma das principais formas de melhoria no gerenciamento das relações das empresas com seus clientes e também parceiros. Definido como um conjunto de atividades com o objetivo de desenvolver e dar continuidade às relações entre a empresa e seus clientes, o MR trata da criação de uma base de relacionamento e integração em todas as fases do relacionamento. Na indústria farmacêutica, caracterizada por estratégias mercadológicas particulares, entre as quais se destaca a mudança de foco do consumidor final para o médico (que prescreve o medicamento), o MR é utilizado de forma constante, sendo disponibilizados altos investimentos nesta área. Com base neste contexto, este trabalho busca investigar a relação entre os incentivos da indústria farmacêutica, caracterizados pelas práticas de MR, e a quantidade de receitas prescritas pelos médicos. Assim, o objetivo central da pesquisa é identificar se o investimento desta indústria em MR junto aos médicos faz com que receite mais o produto. Para tanto, foi realizada uma pesquisa exploratória, utilizando dados secundários de um grande laboratório farmacêutico de nível mundial. Estes dados referem-se a uma amostra de 98 médicos de uma determinada especialidade que foram atendidos pelo Laboratório. Foram testadas as variáveis referentes às práticas de MR – visitas, amostras, congressos, coquetéis e outros, utilizando-se testes de regressão linear. Os resultados comprovaram que os médicos que recebem mais incentivos prescrevem mais receitas. Também foi verificado que existe uma relação positiva entre as práticas de MR e a quantidade de receitas prescritas, sendo que a concessão de inscrições em congressos influencia este resultado de forma mais significativa.

Bens credenciais e poder de mercado : um estudo econométrico da indústria farmacêutica brasileira

The Brazilian pharmaceutical industry has always been targeted by the society, due to the ethical drugs’ high weight in the families’ consumption budgets (especially within the poorer ones) and price raises traditionally above inflation (when the government does not run a price control). The present article aims to organize the debate on regulation for this industry. We review the literature on market failures and regulation solutions adopted for this industry worldwide and try to relate empirically drug prices to some explaining variables, based on original microdata. We find that, similarly to previous U.S. estimations, Brazilian leading brand name drugs – before a 1999 law, which created officially the generic drug defined by its bioequivalence to the reference drug, and a massive advertisement campaign for spreading use of generic drugs, run by the Ministry of Health – accommodated entry and share growth of the followers by raising their prices and catering to a more inelastic market segment. As opposed, the followers reduce relative prices when they lose market. Therefore, a fall of the concentration index in a particular segment has ambiguous effects: if it is due to reduced leader power, the followers raise their relative prices; if it is due to a tougher competition within the fringe, relative prices tend to go down.

Confiança na gestão de equipes de alto desempenho da indústria farmacêutica

Na indústria farmacêutica (IF) são fundamentais as relações de confiança nas equipes de trabalho em todos os níveis. Há um forte impacto das mudanças, e da consequente incerteza, na confiança entre as equipes e sua motivação. Na produção acadêmica recente, as relações entre confiança e desempenho são exploradas e, particularmente, temos os resultados da primeira pesquisa feita no Brasil para mensurar os níveis de confiança interpessoal, indicadores de confiança e comprometimento dos colaboradores dentro de grandes empresas privadas. As empresas estudadas, e comparadas pelo Prof. Zanini, foram representantes da “nova” e “velha” economia, entre as quais os grandes diferenciadores são a gestão do conhecimento e o nível de incerteza decorrente das frequentes mudanças. Estes são pontos que aproximam as empresas da indústria farmacêutica de pesquisa às da “nova” economia segundo a abordagem proposta na pesquisa do Prof. Zanini. As empresas da indústria farmacêutica estarão implementando mudanças importantes em sua forma de conduzir o negócio, principalmente no que toca à comunicação, promoção e gestão das equipes comerciais nos próximos anos e este parece ser um momento particularmente interessante para uma pesquisa como esta. O objetivo deste trabalho foi determinar o nível de similaridade das equipes de propaganda (comerciais) do segmento de produtos biológicos (vacinas) de uma grande empresa multinacional da indústria farmacêutica de pesquisa, com os as equipes de empresas da nova economia. Pretendemos mensurar os níveis de confiança interpessoal, indicadores de confiança e comprometimento dos componentes das equipes comerciais da empresa, com vistas a examinar os efeitos das incertezas institucionais sobre os mesmos. As ferramentas de pesquisa foram: um formulário previamente validado aplicado aos 56 membros da força de vendas de uma área específica da empresa; dados públicos e privados da empresa (que permanecerá identificada como Empresa “J”) e entrevistas em profundidade com os gestores-chave da equipe sob avaliação: gerentes nacionais e distritais da força de vendas. Foi encontrada alguma similaridade entre os índices das empresas da “velha” economia e os da empresa “J”, para a maioria das avaliações. Entretanto, alguma semelhança entre os índices da Empresa “J” e os das empresas da “nova” economia também foi evidenciada, sobretudo na avaliação dos gerentes desta. Isto poderia indicar o impacto de algumas medidas implementadas pela Empresa “J” mais recentemente, que podem ter colaborado na geração de um ambiente de incerteza institucional e instabilidade. A partir da obtenção e comparação destes índices, são propostas considerações sobre as mudanças ocorridas nos contratos relacionais de trabalho dentro da Empresa “J” nos últimos anos e sobre as dinâmicas aparentes nas relações de sua equipe comercial.

Apoio governamental à inovação Tecnológica: análise da indústria farmacêutica paraense

The transformations economical, cultural and social that happen in world ambit they are associated to the intense progress and expansion of new technologies, forcing governments, people, companies and nations to the introduction of new patterns of behavior, forcing, in that way, to the continuous renewal of products and technological processes to maintain the competitiveness, so much among nations, as in the managerial world. In that matter, the technological innovation is recognized as basic factor of maintainable economical competitiveness, being the responsible for the breaking and/or improvement of the techniques and production processes, what presupposes the systematization varied institutional arrangements that they involve firms, interaction nets among companies, government agencies, universities, research institutes, laboratories of companies and scientists and engineers activities. Those arrangements, to the if they articulate with the educational system, with the industrial and managerial section and, also, with the financial institutions, they take the form that Freeman (1987) it coined of national system of innovation, promoted through public politics of CT&I, which seek to induce and to support innovative initiatives in the companies, as well as to establish demands and to prioritize vocations and regional potentialities. In that context of government support to the technological innovation interferes this study, that it looked for to know the reasons of the fragility innovative in the pharmaceutical industry of State of Pará in Brazil, pointed for PINTEC (2005), starting from the point of view of the businessmen of that section. For such, the qualitative approach was used - with interviews directing semi and the technique of the content analysis. The results of the research pointed that the fragilities innovative of the section links to the ignorance of the government support to the technological innovation on the part of the businessmen of the pharmaceutical industry of State of Pará in Brazil

Potencial terapêutico de um heparinóide isolado do invertebrado marinho Litopenaeus vannamei

The occurrence of bioactive compounds in marine organisms comes awaking the interest of the pharmaceutical industry. Heparin, a sulfated polysaccharide which presence was already identified in several marine invertebrates, is very attractive due its remarkable functional versatility. Besides to intervene in blood coagulation, this molecule has a great anti-inflammatory potential. However, its strong anticoagulant activity difficult the clinical exploitation of its anti-inflammatory properties. Thus, the aims of this work were to evaluate the effect of a heparin-like compound (heparinoid), isolated from the cephalotorax of the Litopenaeus vannamei shrimp, on the inflammatory response, hemostasia and synthesis of antithrombotic heparan sulfate by endothelial cells, besides studying some aspects concerning its structure. The purified heparinoid was structurally characterized following an analytical boarding, involving electrophoresis and chromatography. The structural analysis have shown that this compound possess a high content of glucuronic acid residues and disulfated disaccharide units. In contrast to mammalian heparin, the heparinoid was incapable to stimulate the synthesis of heparan sulfate by endothelial cells in the tested concentrations, beyond to show reduced anticoagulant activity and hemorrhagic effect. In a model of acute inflammation, the compound isolated from the shrimp reduced more than 50% of the cellular infiltration. Besides reduce the activity of MMP-9 and proMMP-2 of the peritoneal lavage of inflamed animals, the heparinoid also reduced the activity of MMP-9 secreted by activated human leukocytes. These results demonstrate the potential of heparinoid from L. vannamei to intervene in the inflammatory response. For possessing reduced anticoagulant activity and hemorrhagic effect, this compound can serve as a structural model to direct the development of more specific therapeutical agents to the treatment of inflammatory diseases

Estudo comparativo de carragenanas comerciais Kappa, Iota e Lambda no processo inflamatório em ratos :edema intraplantar e pleurisia

The Iota, Kappa and Lambda commercial carrageenans are rarely pure and normally contain varying amounts of the other types of carrageenans. The exact amount of impurity depends on the seaweed source and extraction procedure. Then, different analysis methods have been applied for determination of the main constituents of carrageenans because these three carrageenans are extensively used in food, cosmetic and pharmaceutical industry. The electrophoresis of these compounds proved that the carrageenans are constituted by sulfated polysaccharides. These compounds were characterized by colorimetric methods and was observed that the Lambda carrageenan shown the greater value (33.38%) of sulfate. These polymers were examined by means of 13C NMR spectroscopy and infrared spectra. The polysaccharides consisted mainly of units alternating of sulfated galactoses and anhydrogalactoses. The aim of the study was also to test the inflammatory action of these different polysaccharides. A suitable model of inflammation is acute sterile inflammation of the rat hind limb induced by carrageenan. Paw edema was induced by injecting carrageenans (κ, ι and λ) in saline into the hind paw of a male Wistar rats (175–200 g). The pathway to acute inflammation by carrageenan (kappa, iota and lambda) were expressed as time-edema dependence and measured by paw edema volume. For this purpose, was used an apparatus (pakymeter), which makes it possible to measure the inflammation (swelling of the rat foot) with sufficient accuracy. The results showed that κ-carrageenan (1%) have an edema of 3.7 mm and the paw edema increase was time and dose dependent; the ι-carrageenan (0.2%) caused an edema of 4 mm and the λ-carrageenan (1%) caused an edema of 3.6 mm. Other model was used in this study based in the inflammation of pleura for comparatives studies. Injection of carrageenans into the pleural cavity of rat induced an acute inflammatory response characterized by fluid accumulation in the pleural cavity, a large number of neutrophils and raised NO production. The levels of NO were measured by Griess reactive. The ι-carrageenan caused the greater inflammation, because it has high concentration of nitrite/nitrate (63.478 nmoles/rat), exudato volume (1.52 ml) and PMNs (4902 x 103 cells). Quantitative evaluation of inflammations of rats is a useful and important parameter for the evaluation of the efficacy of anti-inflammatory drugs

Extração, caracterização estrutural e atividades farmacológicas do olginato obtido da alga marrom Lobophora variegata (Lamouroux) Oliveira Filho, 1977

The alginic acid or alginates are acidic polysaccharides found in brown seaweed widely used in food, cosmetic, medical and pharmaceutical industry. This paper proposes the extraction, chemical characterization and verification of the pharmacological activities of brown seaweed variegata Lobophora . The alginate was extracted from the seaweed Lobophora variegata and part was sulphated for comparative purposes. The native extract showed 42% total sugar, 65% uronic acid, 0,36 % protein and 0% of sulfate, while the sulfate showed 39% , 60%, 0.36% and 27,92 % respectively. The presence of a sulfate group may be observed by the metachromasia with toluidine blue in electrophoresis system and characteristic vibration 1262,34 cm-1 in infrared spectroscopy connections assigned to S = O. We observed the formation of films and beads of native alginate, where more concentrated solution 6% resulted in a thicker and more consistent film. Native alginate showed proliferative activity at concentrations (25 and 50 mcg), (50 mg) and (100 mg) in 3T3 cell line in 24h, 48h and 72h, respectively , as the sulfated (100 mg) in 24 . Also showed antiproliferative or cytotoxic activity in HeLa cells of strain, (25 and 100 mg), (25 and 100 mg) and (25, 50 and 100 mg), to native, now for the sulfate concentrations (100 mg) in 24 (25, 50 and 100 mg) in 48 hours, and (50 and 100 mg ) 72h. For their antioxidant activity, the sulfated alginates have better total antioxidant activity reaching 29 % of the native activity while 7.5 % of activity . For the hydroxyl radical AS showed high inhibition ( between 77-83 % ) in concentrations, but the AN surpassed these numbers in the order of 78-92 % inhibition. The reducing power of AN and AS ranged between 39-82 % . In the method of ferric chelation NA reached 100 % chelating while the AS remained at a plateau oscillating 6.5%. However, in this study , we found alginates with promising pharmacological activities, to use in various industries as an antioxidant / anti-tumor compound

Caracterização de atapulgita visando aplicação para reforço de materiais poloméricos

The clay mineral attapulgite is a group of hormitas, which has its structures formed by microchannels, which give superior technological properties classified the industrial clays, clays of this group has a very versatile range of applications, ranging from the drilling fluid for wells oil has applications in the pharmaceutical industry. Such properties can be improved by activating acid and / or thermal activation. The attapulgite when activated can improve by up to 5-8 times some of its properties. The clay was characterized by X-ray diffraction, fluorescence, thermogravimetric analysis, differential thermal analysis, scanning electron microscopy and transmission electron microscopy before and after chemical activation. It can be seen through the results the efficiency of chemical treatment, which modified the clay without damaging its structure, as well as production of polymer matrix composites with particles dispersed atapugita